Product NDC: | 0469-3211 |
Proprietary Name: | MYCAMINE |
Non Proprietary Name: | micafungin sodium |
Active Ingredient(s): | 20 mg/mL & nbsp; micafungin sodium |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0469-3211 |
Labeler Name: | Astellas Pharma US, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021506 |
Marketing Category: | NDA |
Start Marketing Date: | 20060627 |
Package NDC: | 0469-3211-10 |
Package Description: | 10 VIAL, SINGLE-USE in 1 CARTON (0469-3211-10) > 5 mL in 1 VIAL, SINGLE-USE |
NDC Code | 0469-3211-10 |
Proprietary Name | MYCAMINE |
Package Description | 10 VIAL, SINGLE-USE in 1 CARTON (0469-3211-10) > 5 mL in 1 VIAL, SINGLE-USE |
Product NDC | 0469-3211 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | micafungin sodium |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20060627 |
Marketing Category Name | NDA |
Labeler Name | Astellas Pharma US, Inc. |
Substance Name | MICAFUNGIN SODIUM |
Strength Number | 20 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Echinocandin Antifungal [EPC],Lipopeptides [Chemical/Ingredient] |